Dr. Youwen Zhou
Dr Youwen Zhou is a professor and Director of Research of the Department of Dermatology and Skin Science at University of British Columbia. A certified dermatologist in Canada and US, Dr Zhou received his MD from University of Toronto and PhD from Downstate Medical Center in New York. He serves on the editorial board of JAAD and other dermatology journals. He has received numerous national and international awards and has served on the Advisory Board of CIHR-IMHA Institute. His is the president of Canadian Melanoma Foundation and past president of Canadian Society of Investigative Dermatology. As a clinician scientist, Dr Zhou discovered numerous molecular mediators and pathogenic drivers of cutaneous T cell lymphoma (CTCL) and other skin diseases. His current research is focused on developing next-generation diagnostic tools and targeted therapies for patients with skin inflammation and skin cancers.
Dr. Lucie Germain
Dr. Lucie Germain holds a Ph.D. and pursues a career in regenerative medicine as full professor at Université Laval. Her work at the Tissue Engineering Laboratory/LOEX, a research Centre of the Université Laval is dedicated to post-natal stem cells and the reconstruction of human tissues for experimental and clinical applications. Dr. Germain published more than 155 peer-reviewed articles, 67 book chapters and review articles. She gave more than 135 invited seminars and conferences.
Her sustainable contribution to health research was recognized by the foundation scheme of Canadian Institutes of Health Research (CIHR), which allowed her a financial support for 7 years. Within the CHU de Québec-Université Laval Research Centre, she was Director of the Regenerative Medicine Division until 2014. The Canada research chair program recognized Dr. Germain as a world leader in the field of stem cells and regenerative medicine by granting her a junior Tier-2 chair in 2001 and a senior Tier 1 chair in 2015. Dr. Germain was named Member of the Canadian Academy of Health Sciences in 2013. Between 2014 and 2018, she was appointed Vice-Dean of Research and Graduate Studies at the Faculty of Medicine of Université Laval. In 2005, Dr. Germain received one of the six Quality of Life Research Awards from the IMHA of CIHR. In 2009, she was recognized as Visionary by Châtelaine.
Dr. Kim A. Papp
Research Interests: Psoriasis, Psoriatic Arthritis, Acne, Actinic Keratoses, Atopic Dermatitis (Eczema), Basal Cell Carcinoma, Onychomycosis, Seborrheic Dermatitis, Vaccines
Dr. Kim Papp is a Member of the College of Physicians and Surgeons of Ontario, a Fellow of the Royal College of Physicians and Surgeons of Canada, and a Fellow of the American Academy of Dermatology. The Waterloo, Ontario, Canada based dermatologist has over 25 years’ experience as a Principal Investigator, and has conducted over 170 psoriasis studies in which he closely supervised and assessed over 2750 subjects. Dr. Papp is an internationally renowned Key Opinion Leader in clinical research who conducts clinical trials on a wide range of dermatological disorders.
Dr. Papp, with the support of Probity Medical Research, an organization for which he serves as Founder and President, has earned the distinction of top enrolling investigator in over 70 international dermatology studies.
Dr. Aziz Ghahary
SRGC Frontiers In Science Lecture
Dr. Aziz Ghahary received his Ph.D in Medical Physiology from the University of Manitoba in 1988 and after 2 years as post - doctoral training, he accepted an assistant professorship position in the Department of Surgery at the University of Alberta in 1990. He was then promoted to associate and full professor in 1996 and 2003, respectively. In 2005, he was then recruited by the Department of Surgery/ Plastic Surgery as a full professor and the director of the BC professional Firefighters’ Burn and Wound Healing Research Group. During the last 12 years, 14 Ph.D. and 5 master students have been successfully graduated from his lab.
Funding and publications:
Dr. Ghahary has been awarded more than 52 research grants from local, national and international granting agencies. He is one the well-funded investigator in UBC. He has published or co-published over 185 peer reviewed articles, presented over 220 abstracts and major presentations at national and international conferences.
Discovery and Patents:
Dr. Ghahary has 7 patents from which one is related to a protein called stratifin also known as 14-3-3 sigma. He then found a very high level of eta isoform of 14-3-3 protein in sera of patients with rheumatoid arthritis. This biomarker has now been patented and licensed to the biggest diagnostic company in US and Canada, Quest Diagnostic and Lifelab, respectively. The early RA diagnostic test called JOINTstat, is now available in Canada and US. This has been approved for diagnosis in Europe, Australia, Japan and New Zealand.